Android app on Google Play

Morgan Stanley Resumes Pfizer (PFE) at Overweight

July 10, 2013 6:49 AM EDT Send to a Friend
Get Alerts PFE Hot Sheet
Price: $30.35 +1.00%

Rating Summary:
    14 Buy, 7 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 16 | Down: 14 | New: 38
Trade PFE Now!
Join SI Premium – FREE
Morgan Stanley resumed coverage on Pfizer (NYSE: PFE) with an Overweight. PT $31.00.

For an analyst ratings summary and ratings history on Pfizer click here. For more ratings news on Pfizer click here.

Shares of Pfizer closed at $28.35 yesterday.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Morgan Stanley

Add Your Comment